Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 18/20 | 0.47 |
| ▸ | PRTN3 | P24158 | 5/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12040138 | 0.88 | ELANE (0.40) | ELANEPRTN3KMT2AMAPT | |
| SCHEMBL25844994 | 0.83 | ELANE (0.47) | ELANEPRTN3POLBMAPTPKM | |
| SCHEMBL10204924 | 0.81 | ELANE (0.34) | ELANEMAPT | |
| SCHEMBL2740677 | 0.81 | ELANE (0.54) | ELANEPRTN3POLBMAPTPKM | |
| SCHEMBL25844797 | 0.81 | ELANE (0.46) | ELANEPRTN3POLBMAPTPKM | |
| SCHEMBL2740794 | 0.81 | ELANE (0.41) | ELANEPRTN3 | |
| SCHEMBL13842668 | 0.81 | ELANE (0.45) | ELANEPKM | |
| SCHEMBL27263062 | 0.80 | ELANE (0.51) | ELANEMEN1KMT2AMAPTPKM | |
| SCHEMBL15495793 | 0.80 | ELANE (0.50) | ELANE | |
| SCHEMBL17552769 | 0.80 | ELANE (0.50) | ELANEKMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8906589-B2 | Salt and photoresist composition comprising the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-12-09 | — | — | US | disclosed |
| US-20110200940-A1 | SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110200940-A1 | SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME | FRG1, AFF1, NHERF1 | ELANE 1916/4885PRTN3 331/4885MEN1 327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.